Lake Shore Hma, LLC
Lake Shore Hma, LLC was paid $3.29M by Medicaid between Jan 2018 and Aug 2020, across 117 billing codes. Its largest line is 99283, emergency room visit (moderate) — 12% of everything it billed.
LAKE CITY, FL 32055
Next to other General Acute Care Hospital providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,627 | $445K | |
| 2019 | 55,890 | $1.88M | |
| 2020 | 29,745 | $970K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 7,103 | 6,243 | $400K |
| 36415 | Collection of venous blood by venipuncture | 11% | 8,233 | 5,907 | $360K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.8% | 5,431 | 4,653 | $289K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6.8% | 2,032 | 1,678 | $225K |
| 80053 | Comprehensive metabolic panel | 3.3% | 5,606 | 4,340 | $110K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.3% | 1,042 | 966 | $107K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 3.2% | 693 | 209 | $104K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.1% | 641 | 170 | $103K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.8% | 1,101 | 1,021 | $93K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.7% | 1,962 | 1,606 | $88K |
| 80306 | 2.6% | 2,264 | 1,909 | $86K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 2,376 | 2,064 | $82K |
105 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2.4% | 760 | $79K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 747 | $75K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.1% | 832 | $69K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.1% | 597 | $67K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 1,168 | $53K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.5% | 2,754 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 485 | $50K |
| 81025 | 1.4% | 2,029 | $46K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.2% | 503 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 6,259 | $37K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 787 | $36K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.0% | 684 | $33K |
| 82962 | <1% | 1,113 | $27K | |
| 81001 | <1% | 2,487 | $23K | |
| 86901 | <1% | 377 | $22K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,112 | $21K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,462 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,216 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,278 | $20K |
| 84484 | <1% | 1,842 | $20K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,928 | $19K |
| G0378 | Hospital observation service, per hour | <1% | 940 | $19K |
| 81003 | <1% | 1,797 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,487 | $18K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,368 | $17K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,396 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,063 | $16K |
| 87040 | <1% | 957 | $15K | |
| 76830 | Ultrasound, transvaginal | <1% | 208 | $15K |
| 87430 | <1% | 1,830 | $13K | |
| 96376 | <1% | 870 | $12K | |
| 83880 | <1% | 488 | $12K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 907 | $12K |
| 86850 | <1% | 160 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,438 | $11K |
| 85610 | <1% | 701 | $11K | |
| 83690 | <1% | 1,242 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 141 | $10K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 103 | $9K |
| 85027 | <1% | 846 | $9K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 892 | $9K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 271 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 599 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 216 | $7K |
| 83735 | <1% | 633 | $7K | |
| 82550 | <1% | 605 | $6K | |
| 86900 | <1% | 212 | $6K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 849 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 41 | $5K |
| 74018 | <1% | 255 | $5K | |
| 94761 | <1% | 563 | $5K | |
| 72100 | <1% | 182 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 347 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 983 | $4K |
| 73130 | <1% | 81 | $4K | |
| 73630 | <1% | 142 | $4K | |
| 85730 | <1% | 464 | $4K | |
| 83605 | <1% | 307 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 64 | $4K |
| 80061 | Lipid panel | <1% | 644 | $4K |
| J2704 | Injection, propofol, 10 mg | <1% | 195 | $3K |
| 87186 | <1% | 502 | $3K | |
| 82553 | <1% | 301 | $3K | |
| 87210 | <1% | 209 | $3K | |
| 73610 | <1% | 77 | $3K | |
| 84112 | <1% | 46 | $3K | |
| 36600 | <1% | 135 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 363 | $2K |
| 73564 | <1% | 62 | $2K | |
| 87807 | <1% | 479 | $2K | |
| 87088 | <1% | 282 | $2K | |
| 82803 | <1% | 137 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 340 | $2K |
| 97162 | <1% | 28 | $1K | |
| 73030 | <1% | 45 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 349 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 105 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 260 | $1K |
| 84702 | <1% | 524 | $958.98 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 63 | $917.95 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 51 | $899.72 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 14 | $853.63 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 154 | $838.86 |
| 82150 | <1% | 120 | $838.76 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 18 | $712.25 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 288 | $658.42 |
| 72040 | <1% | 13 | $446.97 | |
| 97164 | <1% | 12 | $416.79 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 32 | $359.60 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 71 | $343.95 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $308.76 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 108 | $287.53 |
| 85378 | <1% | 44 | $267.57 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 60 | $129.87 |
| 86703 | <1% | 61 | $55.67 | |
| 87070 | <1% | 16 | $28.51 | |
| 86592 | <1% | 71 | $20.44 | |
| 82607 | <1% | 97 | $14.27 | |
| 82247 | <1% | 22 | $9.18 | |
| 86762 | <1% | 14 | $4.52 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 126 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 30 | $0.00 |
| 87340 | 0% | 14 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 73 | $0.00 |
| 84439 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.